C186514Level 4
Recombinant Human Hyaluronidase/Trastuzumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of a fixed-dose combination of recombinant human hyaluronidase and trastuzumab that may be used in the treatment of breast cancer.
**Synonyms:** - Herceptin Hylecta Regimen - Hyaluronidase, Recombinant Human/Trastuzumab Regimen - Hyaluronidase-Trastuzumab Regimen - Hyaluronidase-oysk-Trastuzumab Regimen - Hyaluronidase-oysk/Trastuzumab Regimen - Hyaluronidase/Trastuzumab Regimen - Trastuzumab Plus Hyaluronidase-oysk Regimen - Trastuzumab and Hyaluronidase-oysk Regimen - Trastuzumab and hyaluronidase monotherapy - Trastuzumab-Hyaluronidase-oysk Regimen - Trastuzumab/Hyaluronidase-oysk Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C186514Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.